Update on Slump Sale
As filed · Nectar Lifesciences Limited has informed the Exchange about Update on Slump Sale
M&AWatchNotablemateriality 69 out of 100
What happened
FactNectar Lifesciences Limited has informed the Exchange about Update on Slump Sale. Completion of Slump Sale and Asset Sale. the Company has completed the slump sale of its active pharmaceutical ingredients and.
Why it matters
CapitSignal interpretationSelling a business converts an operating asset into cash; what the cash is then used for decides whether holders benefit.
Watch next
Fact- Sale consideration
- Stated use of proceeds
- Revenue and profit leaving the group
Evidence
How CapitSignal classified this
- Reasoning:
- DIVESTMENT base 64; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%